Gilbert syndrome - Revision history

Danbot: Strip excess bold

2026-03-22T09:29:59Z

Strip excess bold

Danbot: Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; bold retained for critical items only

2026-03-19T14:14:47Z

Moved intro paragraph into Background as bullets; removed excessive bold from bullet lead-ins; bold retained for critical items only

Show changes

Ostermayer: Created page with "Gilbert syndrome is the '''most common inherited disorder of bilirubin metabolism''', affecting approximately 5-10% of the general population.Gilbert Syndrome. ''StatPearls''. NCBI. 2024. It is caused by reduced activity (~30% of normal) of the hepatic enzyme '''UGT1A1''' (uridine diphosphate-glucuronosyltransferase 1A1), resulting in '''mild, intermittent unconjugated (indirect) hyperbilirubinemia'''.Gilbert's syndrome revis..."

2026-03-18T00:54:28Z

Created page with "Gilbert syndrome is the '''most common inherited disorder of bilirubin metabolism''', affecting approximately 5-10% of the general population.<ref name="StatPearls">Gilbert Syndrome. ''StatPearls''. NCBI. 2024.</ref> It is caused by reduced activity (~30% of normal) of the hepatic enzyme '''UGT1A1''' (uridine diphosphate-glucuronosyltransferase 1A1), resulting in '''mild, intermittent unconjugated (indirect) hyperbilirubinemia'''.<ref name="JHep">Gilbert's syndrome revis..."

New page

Gilbert syndrome is the '''most common inherited disorder of bilirubin metabolism''', affecting approximately 5-10% of the general population.<ref name="StatPearls">Gilbert Syndrome. ''StatPearls''. NCBI. 2024.</ref> It is caused by reduced activity (~30% of normal) of the hepatic enzyme '''UGT1A1''' (uridine diphosphate-glucuronosyltransferase 1A1), resulting in '''mild, intermittent unconjugated (indirect) hyperbilirubinemia'''.<ref name="JHep">Gilbert's syndrome revisited. ''J Hepatol''. 2023;79(3):818-826. doi:10.1016/j.jhep.2023.06.023</ref> Gilbert syndrome is '''entirely benign''' and does not cause liver disease, hepatic decompensation, or increased mortality. The emergency physician's role is to '''recognize the characteristic pattern''' (isolated unconjugated hyperbilirubinemia with completely normal liver function), '''avoid unnecessary workup and hospitalization''', provide reassurance, and be aware of '''drug metabolism implications''' that may be relevant to ED prescribing.

==Background==
*Autosomal recessive (most common inheritance pattern); prevalence 3-7% in Caucasians; higher in some African populations<ref name="StatPearls"/>
*Male predominance (~3:1 male-to-female ratio)
*Typically recognized in '''adolescence or early adulthood''' — often discovered incidentally on routine blood work or during a stressor (illness, fasting)
*UGT1A1 enzyme activity is reduced to approximately '''30% of normal'''<ref name="MedlinePlus">Gilbert syndrome. ''MedlinePlus Genetics''. NIH. 2024.</ref>
*UGT1A1*28 polymorphism (extra TA repeat in the TATA box promoter region) is the most common genetic variant in Caucasian and African populations; different variants (UGT1A1*6) predominate in Asian populations<ref name="JHep"/>

===Why it matters in the ED===
*Gilbert syndrome is '''extremely common''' — in a busy ED, multiple patients on any given day may have it
*It is the most frequent cause of '''isolated unconjugated hyperbilirubinemia''' encountered by EM physicians
*The primary EM pitfall is '''ordering unnecessary workup''' (hepatitis serologies, imaging, hematologic testing, subspecialty referral) for what is a benign condition
*The secondary EM pitfall is '''attributing jaundice to Gilbert syndrome when a more serious condition is present''' — Gilbert syndrome is a diagnosis of exclusion and should only be invoked when all other causes of unconjugated hyperbilirubinemia have been reasonably ruled out

==Clinical features==
===Typical presentation===
*Patient (often young adult male) presents to the ED for '''another reason''' and is found to have mildly elevated total bilirubin on labs, OR presents with mild '''scleral icterus''' noticed by themselves or others
*Total bilirubin typically '''<3 mg/dL''' (rarely up to 5-6 mg/dL); '''predominantly unconjugated (indirect)'''<ref name="StatPearls"/>
*'''All other liver function tests are completely normal:''' AST, ALT, alkaline phosphatase, GGT, albumin
*'''No hepatosplenomegaly'''
*'''No abdominal pain, pruritus, dark urine, or acholic stools'''
*'''No signs of hemolysis''' (normal reticulocyte count, haptoglobin, LDH, peripheral smear)

===Triggers that may precipitate visible jaundice===
*'''Fasting/caloric restriction''' (the most well-known trigger — bilirubin rises with reduced caloric intake)
*'''Intercurrent illness''' (any febrile illness, infection)
*'''Dehydration'''
*'''Physical overexertion'''
*'''Menstruation'''
*'''Sleep deprivation'''
*'''Emotional stress'''
*'''Surgery/anesthesia'''

===What Gilbert syndrome does NOT cause===
*'''No liver disease, cirrhosis, or hepatic decompensation — ever'''<ref name="JHep"/>
*'''No abdominal pain''' (pain attributed to Gilbert syndrome in older literature is no longer considered part of the condition; investigate other causes)<ref name="JHep"/>
*'''No fatigue''' (fatigue and asthenia previously attributed to Gilbert syndrome are no longer considered features; evaluate other etiologies if present)<ref name="JHep"/>
*'''No conjugated hyperbilirubinemia''' — if the direct fraction is elevated, this is NOT Gilbert syndrome

==Differential diagnosis==
===Unconjugated hyperbilirubinemia (the relevant differential)===
*'''Gilbert syndrome''' (most common; diagnosis of exclusion)
*'''Hemolytic anemias:''' hereditary spherocytosis, G6PD deficiency, sickle cell disease, autoimmune hemolytic anemia, TTP/HUS, mechanical hemolysis (prosthetic valve)
*'''Resorbing hematoma''' (large bruise, retroperitoneal hemorrhage)
*'''Ineffective erythropoiesis''' (megaloblastic anemia, thalassemia)
*'''[[Crigler-Najjar syndrome]]:''' type 1 (complete UGT1A1 absence; severe neonatal jaundice; bilirubin >20 mg/dL; risk of kernicterus) or type 2 (partial deficiency; bilirubin typically 6-20 mg/dL; responds to phenobarbital)
*'''Heart failure''' (impaired hepatic bilirubin uptake from congestion)
*'''Portosystemic shunts'''
*'''Medications:''' rifampin, probenecid, some HIV antivirals
*'''[[Wilson disease]]''' (rare; can cause unconjugated hyperbilirubinemia from hemolysis)

===Conditions that Gilbert syndrome may coexist with (additive effect)===
*'''G6PD deficiency + Gilbert syndrome:''' the combination significantly increases risk of severe neonatal hyperbilirubinemia and may cause more pronounced jaundice during hemolytic episodes in adulthood
*'''Hereditary spherocytosis + Gilbert syndrome:''' similarly additive
*Gilbert syndrome alone does not cause neonatal kernicterus, but when combined with hemolytic conditions, it can amplify neonatal hyperbilirubinemia to dangerous levels

==Evaluation==
===The ED evaluation should be minimal===
*'''Fractionated bilirubin''' (total and direct): confirms that hyperbilirubinemia is '''unconjugated (indirect)''' — this is the essential first step
*'''Hepatic panel''' (AST, ALT, alkaline phosphatase, albumin): '''must be entirely normal''' to attribute jaundice to Gilbert syndrome
*'''CBC with reticulocyte count:''' to exclude hemolysis (reticulocyte count should be normal in isolated Gilbert syndrome)
*'''Peripheral blood smear:''' if hemolysis is suspected (spherocytes, schistocytes, sickle cells)
*'''Haptoglobin, LDH:''' to exclude hemolysis (should be normal in Gilbert syndrome)

===Criteria that support Gilbert syndrome (diagnosis of exclusion)===
*Isolated unconjugated hyperbilirubinemia (total bilirubin typically <3 mg/dL; direct fraction normal)
*'''All liver enzymes and synthetic function tests normal'''
*'''No evidence of hemolysis''' (normal reticulocyte count, haptoglobin, LDH, smear)
*'''No evidence of structural liver disease'''
*History of intermittent mild jaundice, often with identifiable triggers
*Often positive family history (autosomal recessive)

===Tests that are NOT needed===
*'''Genetic testing (UGT1A1 genotyping):''' not required for diagnosis in most cases; considered obsolete as a routine diagnostic tool<ref name="JHep"/>
*'''Fasting test:''' historically used (24-48 hour fast provokes bilirubin rise); '''no longer recommended''' as a diagnostic maneuver<ref name="JHep"/>
*'''Phenobarbital test:''' historically used (phenobarbital reduces bilirubin by inducing UGT1A1); obsolete
*'''Liver biopsy:''' never indicated
*'''Hepatobiliary imaging:''' not needed if liver panel is completely normal and bilirubin is unconjugated
*'''Hepatitis serologies:''' not needed for isolated unconjugated hyperbilirubinemia with normal enzymes (hepatitis causes conjugated hyperbilirubinemia and elevated transaminases)

==Management==
===No treatment is required===
*Gilbert syndrome is '''entirely benign''' and requires no therapy<ref name="JHep"/>
*The mainstay of management is '''reassurance and education'''
*Inform the patient that:
**This is a common, harmless genetic variant
**Mild jaundice may recur intermittently, especially with fasting, illness, or stress
**It does not progress to liver disease
**It does not shorten lifespan (and may actually confer some cardiovascular benefit through bilirubin's antioxidant properties)
**Future lab testing may show elevated bilirubin — inform other healthcare providers to prevent unnecessary repeat workup

===Drug metabolism considerations===

UGT1A1 metabolizes not only bilirubin but also certain drugs. Patients with Gilbert syndrome may be at '''increased risk of toxicity''' from medications that rely on UGT1A1 for glucuronidation:<ref name="StatPearls"/>

{| class="wikitable"
|-
! Drug !! Clinical relevance !! Risk
|-
| '''Irinotecan''' (chemotherapy) || Active metabolite SN-38 accumulates → severe diarrhea and myelosuppression || '''Life-threatening;''' FDA recommends UGT1A1 genotyping before prescribing
|-
| '''Atazanavir, indinavir''' (HIV protease inhibitors) || Inhibit UGT1A1 → worsened hyperbilirubinemia, visible jaundice || Usually cosmetic only; rarely requires drug change
|-
| '''Acetaminophen''' || Glucuronidation is a minor pathway; some Gilbert syndrome patients may have reduced clearance || Unlikely to be clinically significant at therapeutic doses; avoid excessive doses
|-
| '''Morphine''' || Glucuronidated by UGT enzymes || Theoretical risk of prolonged effect; monitor
|-
| '''Lorazepam, oxazepam''' || Glucuronidated benzodiazepines || Theoretical risk; clinical significance uncertain
|-
| '''Lamotrigine''' || Glucuronidated by UGT1A4 (related enzyme) || May require dose adjustment
|-
| '''NSAIDs''' || Some are glucuronidated || Clinical significance unclear in Gilbert syndrome
|}

*'''Do NOT reduce chemotherapy doses based on elevated bilirubin alone in Gilbert syndrome patients''' — the bilirubin elevation reflects impaired conjugation, not hepatic dysfunction; dose adjustments based on bilirubin as a surrogate for liver function are inappropriate in this context<ref name="OncoGS">Ha VH, et al. Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1. ''Pharmacotherapy''. 2017;37(9):1082-1091.</ref>

==Disposition==
*'''Discharge home''' — Gilbert syndrome is not a reason for admission, further ED workup, or specialist referral
*'''Clear documentation:''' note the diagnosis in the chart to prevent future unnecessary workup
*'''Reassurance is the treatment:''' many patients are anxious about jaundice or "abnormal liver labs" — explain that this is a benign genetic variant shared by millions of people
*'''Outpatient follow-up:''' with primary care physician for routine monitoring (no specific hepatology follow-up needed unless diagnostic uncertainty remains)
*'''Advise the patient to:'''
**Inform future healthcare providers of their Gilbert syndrome diagnosis
**Maintain regular meals and hydration (fasting exacerbates jaundice)
**Report any new symptoms (abdominal pain, dark urine, pale stools, pruritus, persistent fatigue) — these would suggest a ''different'' diagnosis

==See Also==
*[[Neonatal jaundice]]
*[[Neonatal hepatitis]]
*[[Crigler-Najjar syndrome]]
*[[Hemolytic anemia]]
*[[G6PD deficiency]]
*[[Hereditary spherocytosis]]
*[[Wilson disease]]

==External Links==
*[https://www.ncbi.nlm.nih.gov/books/NBK470200/ StatPearls — Gilbert Syndrome]
*[https://www.journal-of-hepatology.eu/article/S0168-8278(23)00421-X/fulltext J Hepatol — Gilbert's syndrome revisited (2023)]
*[https://medlineplus.gov/genetics/condition/gilbert-syndrome/ MedlinePlus — Gilbert Syndrome]
*[https://www.ncbi.nlm.nih.gov/books/NBK294473/ NCBI Bookshelf — Irinotecan Therapy and UGT1A1 Genotype]

==References==
<references/>

[[Category:GI]]
[[Category:Metabolic]]

← Older revision		Revision as of 09:29, 22 March 2026
Line 4:		Line 4:
	*Autosomal recessive (most common inheritance pattern); prevalence 3-7% in Caucasians; higher in some African populations<ref name="StatPearls"/>		*Autosomal recessive (most common inheritance pattern); prevalence 3-7% in Caucasians; higher in some African populations<ref name="StatPearls"/>
	*Male predominance (~3:1 male-to-female ratio)		*Male predominance (~3:1 male-to-female ratio)
	*Typically recognized in ~~'''~~adolescence or early adulthood~~'''~~ — often discovered incidentally on routine blood work or during a stressor (illness, fasting)		*Typically recognized in adolescence or early adulthood — often discovered incidentally on routine blood work or during a stressor (illness, fasting)
	*UGT1A1 enzyme activity is reduced to approximately ~~'''~~30% of normal~~'''~~<ref name="MedlinePlus">Gilbert syndrome. ''MedlinePlus Genetics''. NIH. 2024.</ref>		*UGT1A1 enzyme activity is reduced to approximately 30% of normal<ref name="MedlinePlus">Gilbert syndrome. ''MedlinePlus Genetics''. NIH. 2024.</ref>
	UGT1A128 polymorphism (extra TA repeat in the TATA box promoter region) is the most common genetic variant in Caucasian and African populations; different variants (UGT1A1*6) predominate in Asian populations<ref name="JHep"/>		UGT1A128 polymorphism (extra TA repeat in the TATA box promoter region) is the most common genetic variant in Caucasian and African populations; different variants (UGT1A1*6) predominate in Asian populations<ref name="JHep"/>

	===Why it matters in the ED===		===Why it matters in the ED===
	*Gilbert syndrome is ~~'''~~extremely common~~'''~~ — in a busy ED, multiple patients on any given day may have it		*Gilbert syndrome is extremely common — in a busy ED, multiple patients on any given day may have it
	*It is the most frequent cause of ~~'''~~isolated unconjugated hyperbilirubinemia~~'''~~ encountered by EM physicians		*It is the most frequent cause of isolated unconjugated hyperbilirubinemia encountered by EM physicians
	*The primary EM pitfall is ~~'''~~ordering unnecessary workup~~'''~~ (hepatitis serologies, imaging, hematologic testing, subspecialty referral) for what is a benign condition		*The primary EM pitfall is ordering unnecessary workup (hepatitis serologies, imaging, hematologic testing, subspecialty referral) for what is a benign condition
	*The secondary EM pitfall is ~~'''~~attributing jaundice to Gilbert syndrome when a more serious condition is present~~'''~~ — Gilbert syndrome is a diagnosis of exclusion and should only be invoked when all other causes of unconjugated hyperbilirubinemia have been reasonably ruled out		*The secondary EM pitfall is attributing jaundice to Gilbert syndrome when a more serious condition is present — Gilbert syndrome is a diagnosis of exclusion and should only be invoked when all other causes of unconjugated hyperbilirubinemia have been reasonably ruled out

	==Clinical features==		==Clinical features==
	===Typical presentation===		===Typical presentation===
	*Patient (often young adult male) presents to the ED for ~~'''~~another reason~~'''~~ and is found to have mildly elevated total bilirubin on labs, OR presents with mild ~~'''~~scleral icterus~~'''~~ noticed by themselves or others		*Patient (often young adult male) presents to the ED for another reason and is found to have mildly elevated total bilirubin on labs, OR presents with mild scleral icterus noticed by themselves or others
	*Total bilirubin typically '''<3 mg/dL''' (rarely up to 5-6 mg/dL); '''predominantly unconjugated (indirect)'''<ref name="StatPearls"/>		*Total bilirubin typically '''<3 mg/dL''' (rarely up to 5-6 mg/dL); '''predominantly unconjugated (indirect)'''<ref name="StatPearls"/>
	* All other liver function tests are completely normal: AST, ALT, alkaline phosphatase, GGT, albumin		* All other liver function tests are completely normal: AST, ALT, alkaline phosphatase, GGT, albumin
Line 58:		Line 58:
	==Evaluation==		==Evaluation==
	===The ED evaluation should be minimal===		===The ED evaluation should be minimal===
	* Fractionated bilirubin (total and direct): confirms that hyperbilirubinemia is ~~'''~~unconjugated (indirect)~~'''~~ — this is the essential first step		* Fractionated bilirubin (total and direct): confirms that hyperbilirubinemia is unconjugated (indirect) — this is the essential first step
	* Hepatic panel (AST, ALT, alkaline phosphatase, albumin): '''must be entirely normal''' to attribute jaundice to Gilbert syndrome		* Hepatic panel (AST, ALT, alkaline phosphatase, albumin): '''must be entirely normal''' to attribute jaundice to Gilbert syndrome
	* CBC with reticulocyte count: to exclude hemolysis (reticulocyte count should be normal in isolated Gilbert syndrome)		* CBC with reticulocyte count: to exclude hemolysis (reticulocyte count should be normal in isolated Gilbert syndrome)
Line 74:		Line 74:
	===Tests that are NOT needed===		===Tests that are NOT needed===
	* Genetic testing (UGT1A1 genotyping): not required for diagnosis in most cases; considered obsolete as a routine diagnostic tool<ref name="JHep"/>		* Genetic testing (UGT1A1 genotyping): not required for diagnosis in most cases; considered obsolete as a routine diagnostic tool<ref name="JHep"/>
	* Fasting test: historically used (24-48 hour fast provokes bilirubin rise); ~~'''~~no longer recommended~~'''~~ as a diagnostic maneuver<ref name="JHep"/>		* Fasting test: historically used (24-48 hour fast provokes bilirubin rise); no longer recommended as a diagnostic maneuver<ref name="JHep"/>
	* Phenobarbital test: historically used (phenobarbital reduces bilirubin by inducing UGT1A1); obsolete		* Phenobarbital test: historically used (phenobarbital reduces bilirubin by inducing UGT1A1); obsolete
	* Liver biopsy: never indicated		* Liver biopsy: never indicated
Line 82:		Line 82:
	==Management==		==Management==
	===No treatment is required===		===No treatment is required===
	*Gilbert syndrome is ~~'''~~entirely benign~~'''~~ and requires no therapy<ref name="JHep"/>		*Gilbert syndrome is entirely benign and requires no therapy<ref name="JHep"/>
	*The mainstay of management is ~~'''~~reassurance and education~~'''~~		*The mainstay of management is reassurance and education
	*Inform the patient that:		*Inform the patient that:
	**This is a common, harmless genetic variant		**This is a common, harmless genetic variant